Literature DB >> 25688270

Fatal retroperitoneal bleeding caused by neurofibromatosis: a case report and review of the literature.

Patrick R Moerbeek1, Jesse M van Buijtenen1, Baukje van den Heuvel1, Arjan W J Hoksbergen1.   

Abstract

A young female was brought into the emergency department with pulseless electrical activity (PEA) after local resection of neurofibromateous lesions. Chest ultrasonography was normal. Abdominal ultrasonography was not performed. After successful resuscitation a total body CT-scan was performed to rule out potential bleeding sources. However, haemodynamic instability reoccurred and the scan had to be aborted at the thoracoabdominal level. No thoracic abnormalities were found. Resuscitation was reinitiated and abdominal ultrasonography was performed, showing a large amount of abdominal fluid. A progressive fall in haemoglobin was noted. Emergency laparotomy was performed, revealing a large retroperitoneal haematoma. Despite ligation and packing, bleeding continued. Postoperative angiography showed active bleeding from a branch of the left internal iliac artery, which could be successfully coiled. Unfortunately, the patient died five days later due to irreversible brain damage. Revision of an MRI scan made one year earlier showed a 10 cm large retroperitoneal neurofibromatous lesion exactly at the location of the current bleeding. This case shows that patients with neurofibromatosis might develop spontaneous life-threatening bleeding from retroperitoneal located lesions. Furthermore, it points out the necessity of focused assessment with ultrasonography of the abdomen in all patients with PEA of unknown origin.

Entities:  

Year:  2015        PMID: 25688270      PMCID: PMC4321078          DOI: 10.1155/2015/965704

Source DB:  PubMed          Journal:  Case Rep Med


1. Case Report

A 33-year-old female with a medical history of neurofibromatosis type 1 and scoliosis was presented to our emergency department with PEA. She collapsed at home after complaints of “heavy arms” and nausea some hours after local excision of numerous cutaneous neurofibromatous lesions in another hospital. Surgery had been performed under general anaesthesia and local application of ropivacaine (a local anaesthetic of the amide type). At arrival of the paramedics asystole was found and immediate resuscitation was started, regaining cardiac output and blood pressure. During transport cardiac arrest reoccurred, forcing the ambulance staff to divert her to the nearest hospital. After regaining output, sinus rhythm of 70 beats/min with blood pressure of 80/60 mmHg was established. The initial lactate was 21 mmol/L, glucose 31 mmol/L, and haemoglobin 6.0 mmol/L. Arterial blood gasses showed a pH 6.5 mmol/L, potassium 5.5 mmol/L, pO2 287 mmHg, and sO2 of 98%. The initial consideration was anaphylactic shock caused by the local anaesthetics, diabetic ketoacidosis de novo, or pulmonary embolism. Immediate chest ultrasonography showed no signs of pulmonary embolism or cardiac tamponade. Since the surgery earlier that day involved only cutaneous resections and there had been no abdominal complaints, an abdominal cause was not immediately suspected. After stabilizing the patient a total-body CT-scan was made to rule out potential bleeding sources. However, during this process haemodynamic instability reoccurred requiring instant resuscitation and transport to the intensive care unit (ICU). The CT-scan had to be aborted at the diaphragm level and showed no intracerebral or thoracic abnormalities. During the second resuscitation a significant fall in haemoglobin was noted. Abdominal ultrasonography now showed a large amount of abdominal fluid and clots. Laceration of the liver or spleen due to the chest compressions during resuscitation was suspected and because of ongoing hemodynamic instability immediate laparotomy was performed. A large expanding retroperitoneal haematoma in the left lower quadrant of the abdomen was identified and explored showing a bleeding at the level of the lumbar vertebrae. Attempts were made to control the haemorrhage by suturing, application of local haemostatics, and gauze packing. Despite these efforts, the bleeding persisted postoperatively and angiography was performed. Contrast extravasation from a dorsal branch of the left internal iliac artery was identified and was successfully coiled (Figures 1 and 2). After this procedure the patient stabilized and was transferred to the ICU.
Figure 1

Angiography showing a blush from a dorsal branch from the left internal iliac artery (arrow).

Figure 2

Angiography showing successful coiling of the bleeding artery.

In total 31 units of packed cells, 22 units of fresh frozen plasma cells, and 7 units of thrombocytes were infused. Unfortunately 5 days later the patient died because of severe irreversible ischemic brain damage. Autopsy was declined by the family. After her death an MRI scan made one year earlier in the hospital where she was known was revised and revealed a 10 cm large neurofibromatous lesion exactly at the location of the present haemorrhage (Figure 3). This knowledge was unfortunately not available at the time of presentation.
Figure 3

MRI scan showing the retroperitoneal NF1 lesion (arrow) at the bleeding site. Lateral displacement of left psoas muscle due to tumour growth.

2. Discussion

Neurofibromatosis (NF) is a genetically autosomal dominant inherited condition in which tumours grow from nerve tissue [1]. There are two types of NF. NF type I, also known as Von Recklinghausen's disease, causes mostly neurocutaneous lesions. It is also the most common type, accounting for 90% of all neurofibromatosis cases, with an incidence of 1 in 3000. NF type II is seen in the central nerve system and is less common with an incidence of 1 in 45000. The clinical manifestations of NF1 are extremely variable. The hallmarks of NF1 are multiple “café-au-lait” spots and associated cutaneous neurofibromas. Four types of neurofibromas can be distinguished mainly based on their origin: cutaneous, subcutaneous, nodular, and diffuse plexiform types. The diffuse plexiform type of neurofibromatosis is the most vascularized type. In 5–15% the benign neurofibromas may convert to malignant tumours [2]. Up to 25% of NF1 patients develop gastrointestinal stromal tumours (GISTs) with nonspecific presentations [3]. There is no specific treatment for NF1; however monitoring is advised. Lesions may be resected if desirable [4]. Vascular manifestations of NF1, such as occlusion, stenosis, aneurysm, and ectasia, were first described in 1945 [5]. The incidence of vascular involvement of NF1, mainly stenosis and aneurysms, is approximately 3.6% [6]. Arterial rupture, fistulas, and occlusion are rare and are presumably caused by arterial fragility secondary to arterial dysplasia or vascular invasion by the neurofibroma [5, 7]. Vasculopathy can range from large vessels in visceral organs to small vessels in soft tissue [8]. A review of the English literature from 1957 to 2007 by Oderich et al. showed 237 patients with NF1 with 320 vascular abnormalities [9]. This number, however, is probably underestimated, as most of the lesions are clinically silent. Arterial thickening, stenosis, and aneurysms are frequently seen in postmortal examinations [10]. Haemorrhage caused by neurofibromatosis can be severe. Several cases have been described. The sites of bleeding most frequently seen are intrathoracic [1], intraluminal (GISTs) [3], and subcutaneous [11]. Cerebral, organic, and retroperitoneal haemorrhages are less commonly described. Vascular involvement is considered to be one of the most important causes of early death in patients with NF1 [7, 12–14]. Most vascular lesions are diagnosed after complaints of pain or haemorrhage and are found at a mean age of the patients of 38 (±16 years). Diagnosis of spontaneous abdominal or retroperitoneal haemorrhage is often delayed or missed. When such a bleeding occurs from NF1, patients may rapidly develop hypovolemic shock. Life expectancy in NF1 patients is 15 years shorter with a mean age of 59 years. After malignancy, bleeding is the second cause of early death especially in patients under the age of 40 [9]. Unfamiliarity with the pathophysiology of NF1 may lead to delayed diagnosis and treatment in patients presenting with hypovolemic shock. Focused assessment with sonography of the abdomen, which can easily be performed in the emergency room during initial workup, is a fast and helpful tool to identify abdominal haemorrhage and facilitate decision-making [15]. Since haemorrhage is typically seen in NF1 patients in their 3rd and 4th decades, screening for neurofibromas with possible vascular involvement in this group seems opportune. Also the potential malignant conversion may warrant screening and frequent follow-up in this particular group. However, Wolkenstein et al. [16] reported minimal benefits of screening investigations solely based on chest X-rays and abdominal ultrasonography. Nowadays low-dose CT-scanning and MRI are widely available and sensitivity and specificity are superior to ultrasound. In this way lesions with vascular involvement might be identified in an earlier stage and sudden, potentially lethal, haemorrhage might be prevented. Several cases describe successful endovascular treatment of acute haemorrhage in NF1, even from multiple bleeding sites [11, 13, 17–19]. Failure after coiling, however, has been described [20]. Treatment of retroperitoneal bleeding in hemodynamically unstable patients remains challenging. Whether patients are treated best with angiography and coiling and/or surgical packing depends on several factors including haemodynamic instability, diagnosis, bleeding site, and local expertise and experience.

3. Conclusion

Neurofibromatous lesions can be located intra-abdominally or retroperitoneally and may cause serious bleeding due to vascular involvement, especially in relatively young patients. In patients with a history of neurofibromatosis who present with sudden collapse and pulseless electrical activity, urgent identification of possible abdominal haemorrhage is essential. Focused assessment with sonography during initial workup in such patients is a fast and helpful tool to identify an abdominal source of bleeding.
  17 in total

1.  Von Recklinghausen's disease: a clinicopathological study.

Authors:  R D Brasfield; T K Das Gupta
Journal:  Ann Surg       Date:  1972-01       Impact factor: 12.969

2.  Spontaneous hemorrhage within the neck of a neurofibromatosis type 1 patient.

Authors:  Min Chen Hung; Eric Yang; Ying C Huang; Ruey-Sheng Chang
Journal:  J Emerg Med       Date:  2011-06-29       Impact factor: 1.484

3.  Recurrent hematochezia secondary to gastrointestinal stromal tumors (GISTs) in neurofibromatosis type one.

Authors:  Justin T Kupec; H James Williams; Andrew K Roorda; Stephan U Goebel
Journal:  W V Med J       Date:  2011 Jul-Aug

Review 4.  Gastrointestinal neurofibromatosis: an unusual cause of gastric outlet obstruction.

Authors:  Jennifer R Bakker; Marian M Haber; Fernando U Garcia
Journal:  Am Surg       Date:  2005-02       Impact factor: 0.688

5.  Ruptured aneurysm of intercostal arteriovenous malformation associated with neurofibromatosis type 1: a case report.

Authors:  Hyung Jun Kim; Hyun Ju Seon; Song Choi; Nam Kyu Jang
Journal:  Cardiovasc Intervent Radiol       Date:  2010-08-15       Impact factor: 2.740

6.  Sudden death due to a dissecting intramural hematoma of the esophagus (DIHE) in a woman with severe neurofibromatosis-related scoliosis.

Authors:  Cristoforo Pomara; Stefania Bello; Stefano D'Errico; Michele Greco; Vittorio Fineschi
Journal:  Forensic Sci Int       Date:  2013-02-28       Impact factor: 2.395

7.  Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results.

Authors:  Gustavo S Oderich; Timothy M Sullivan; Thomas C Bower; Peter Gloviczki; Dylan V Miller; Dudica Babovic-Vuksanovic; Thanila A Macedo; Anthony Stanson
Journal:  J Vasc Surg       Date:  2007-07-30       Impact factor: 4.268

8.  The endovascular management of a neurofibromatosis vasculopathy: a case report.

Authors:  Andrew Choong; Swethan Alagaratnam; Samir Suliman; Panagiotis Gikas; Timothy Briggs; Alexander Loh; Kevin Lotzof
Journal:  Vasc Endovascular Surg       Date:  2012-07-31       Impact factor: 1.089

Review 9.  Clinical and genetic aspects of neurofibromatosis 1.

Authors:  Kimberly Jett; Jan M Friedman
Journal:  Genet Med       Date:  2010-01       Impact factor: 8.822

10.  Fatal retroperitoneal bleeding caused by metastasis of a sigmoid carcinoma.

Authors:  Cornelis G Vos; Arjan W J Hoksbergen
Journal:  Case Rep Med       Date:  2011-08-16
View more
  5 in total

1.  Spontaneous Near Fatal Hemorrhage into Neurofibromatosis Type 1 Lesion in the Scalp.

Authors:  Edwin Stephen; Rajeev Kariyattil; Alok Mittal; Faisal Al-Azri; Khalifa Al-Wahaibi
Journal:  Oman Med J       Date:  2022-05-31

2.  Delayed hydronephrosis due to retroperitoneal hematoma after a seatbelt injury: A case report.

Authors:  Tetsuya Yumoto; Yoshitaka Kondo; Kento Kumon; Yoshihisa Masaoka; Takao Hiraki; Taihei Yamada; Hiromichi Naito; Atsunori Nakao
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

3.  Developing Cervical Hematoma Following Jaw Thrust Maneuver Triggered Diagnosis of Neurofibromatosis: A Case Report and Brief Literature Review.

Authors:  Behzad Nemati Honar; Alireza Mirkheshti; Elham Memary
Journal:  Anesth Pain Med       Date:  2017-01-14

4.  Spontaneous rupture of the pancreatic arcade artery caused by neurofibromatosis type 1 successfully treated using emergency transcatheter arterial embolization, partial intra-aortic balloon occlusion, and stent graft placement: a case report and review of the literature.

Authors:  Ryo Morita; Daisuke Abo; Takeshi Soyama; Yuki Yoshino; Toru Yoshikawa; Tasuku Kimura; Kohsuke Kudo
Journal:  CVIR Endovasc       Date:  2020-07-26

5.  [Lethal Hemomediastinum due to Spontaneous Rupture of an Aberrant Bronchial Artery in a Patient with Neurofibromatosis Type 1: Successful Treatment with Embolization].

Authors:  Yun Jin Im; Min Jeong Choi; Bong Man Kim
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2020-06-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.